These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 9861778

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Enhanced lipid peroxidation in hepatic cirrhosis.
    Pratico D, Iuliano L, Basili S, Ferro D, Camastra C, Cordova C, FitzGerald GA, Violi F.
    J Investig Med; 1998 Feb; 46(2):51-7. PubMed ID: 9549227
    [Abstract] [Full Text] [Related]

  • 3. Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites.
    Alam I, Bass NM, Bacchetti P, Gee L, Rockey DC.
    Am J Gastroenterol; 2000 Jan; 95(1):199-203. PubMed ID: 10638583
    [Abstract] [Full Text] [Related]

  • 4. Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt.
    Trebicka J, Krag A, Gansweid S, Appenrodt B, Schiedermaier P, Sauerbruch T, Spengler U.
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1218-25. PubMed ID: 21971377
    [Abstract] [Full Text] [Related]

  • 5. Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension.
    La Mura V, Reverter JC, Flores-Arroyo A, Raffa S, Reverter E, Seijo S, Abraldes JG, Bosch J, García-Pagán JC.
    Gut; 2011 Aug; 60(8):1133-8. PubMed ID: 21427197
    [Abstract] [Full Text] [Related]

  • 6. [Plasma prostacyclin (PGI2) levels in peripheral venous, arterial and portal venous blood in cirrhotic patients with portal hypertension and their clinical implication].
    Yin J, Leng X, Zhu J.
    Zhonghua Wai Ke Za Zhi; 1995 Sep; 33(9):563-5. PubMed ID: 8731881
    [Abstract] [Full Text] [Related]

  • 7. Plasma substance P levels in patients with liver cirrhosis: relationship to systemic and portal hemodynamics.
    Lee FY, Lin HC, Tsai YT, Chang FY, Lu RH, Hou MC, Li CP, Chu CJ, Wang SS, Lee SD.
    Am J Gastroenterol; 1997 Nov; 92(11):2080-4. PubMed ID: 9362197
    [Abstract] [Full Text] [Related]

  • 8. Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS.
    Holland-Fischer P, Grønbæk H, Sandahl TD, Moestrup SK, Riggio O, Ridola L, Aagaard NK, Møller HJ, Vilstrup H.
    Gut; 2011 Oct; 60(10):1389-93. PubMed ID: 21572121
    [Abstract] [Full Text] [Related]

  • 9. [Plasma level of glucagon in cirrhotic patients with portal hypertension during operation of portacaval shunts].
    Feng H, Zhang Z, Leng X, Li S, Zhu J, Du R.
    Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):222-4. PubMed ID: 11829825
    [Abstract] [Full Text] [Related]

  • 10. [The levels of renin activity, angiotensin converting enzyme and angiotensin II in cirrhotic patients with ascites undergoing portacaval shunt].
    Zhang Z, Feng H, Leng X, Ma F, Wang B, Du R.
    Zhonghua Wai Ke Za Zhi; 1999 Jun; 37(6):366-8. PubMed ID: 11829864
    [Abstract] [Full Text] [Related]

  • 11. Ongoing prothrombotic state in the portal circulation of cirrhotic patients.
    Violi F, Ferro D, Basili S, Lionetti R, Rossi E, Merli M, Riggio O, Bezzi M, Capocaccia L.
    Thromb Haemost; 1997 Jan; 77(1):44-7. PubMed ID: 9031447
    [Abstract] [Full Text] [Related]

  • 12. Effects of splenic artery occlusion on portal pressure in patients with cirrhosis and portal hypertension.
    Luca A, Miraglia R, Caruso S, Milazzo M, Gidelli B, Bosch J.
    Liver Transpl; 2006 Aug; 12(8):1237-43. PubMed ID: 16741929
    [Abstract] [Full Text] [Related]

  • 13. Comparative study of coagulation and thrombin generation in the portal and jugular plasma of patients with cirrhosis.
    Delahousse B, Labat-Debelleix V, Decalonne L, d'Alteroche L, Perarnau JM, Gruel Y.
    Thromb Haemost; 2010 Oct; 104(4):741-9. PubMed ID: 20806106
    [Abstract] [Full Text] [Related]

  • 14. Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery.
    Kim JJ, Dasika NL, Yu E, Fontana RJ.
    J Clin Gastroenterol; 2009 Jul; 43(6):574-9. PubMed ID: 19169145
    [Abstract] [Full Text] [Related]

  • 15. Serum laminin P1 levels do not reflect critically elevated portal pressure in patients with liver cirrhosis.
    Bahr MJ, Böker KH, Horn W, Günzler V, Manns MP.
    Hepatogastroenterology; 1997 Jul; 44(16):1200-5. PubMed ID: 9261625
    [Abstract] [Full Text] [Related]

  • 16. Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: effects of transjugular intrahepatic portosystemic shunts.
    Chalasani N, Gorski JC, Patel NH, Hall SD, Galinsky RE.
    Hepatology; 2001 Dec; 34(6):1103-8. PubMed ID: 11731998
    [Abstract] [Full Text] [Related]

  • 17. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
    Wong W, Liu P, Blendis L, Wong F.
    Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381
    [Abstract] [Full Text] [Related]

  • 18. The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.
    Colombato L.
    J Clin Gastroenterol; 2007 Mar; 41 Suppl 3():S344-51. PubMed ID: 17975487
    [Abstract] [Full Text] [Related]

  • 19. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.
    Laviña B, Gracia-Sancho J, Rodríguez-Vilarrupla A, Chu Y, Heistad DD, Bosch J, García-Pagán JC.
    Gut; 2009 Jan; 58(1):118-25. PubMed ID: 18829979
    [Abstract] [Full Text] [Related]

  • 20. [Adrenoceptors in the hepatic tissues in cirrhotic rats and cirrhotic patients with portal hypertension].
    Feng H, Leng X, Zhang Z.
    Zhonghua Yi Xue Za Zhi; 1997 Mar; 77(3):175-7. PubMed ID: 9596953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.